Novavax COVID-19 Vaccine Is 90% Effective, But Authorization Is Complicated
Novavax said Monday its COVID-19 vaccine is 90.4 percent effective against the original coronavirus, but the company may face several extra months of FDA review.
Stanley Erck
News About Stanley Erck
Johnson & Johnson’s COVID-19 Vaccine Is Effective Enough For Mass Use
But the South African variant is still a major concern.
